Quasar Medical, a global contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices, announces the acquisition of the Medres’ Nitinol Design and Development Center in San Diego, California. The acquisition significantly expands Quasar’s capabilities in advanced Nitinol design, development, and manufacturing, while strengthening its global technology organization under the leadership of Christine Trepanier, Senior Vice President of Technology. The transaction includes the 10,000-square-foot site in San Diego, CA, established in 2024, with dedicated Nitinol operations, engineering talent, and manufacturing capabilities.
Read the full article: Quasar Medical Acquires Nitinol Design and Development Center //
Source: https://www.prnewswire.com/news-releases/quasar-medical-acquires-nitinol-design-and-development-center-302839603.html